Bulletin
Investor Alert

Enfusion Inc.

NYS: ENFN

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Jan 28, 2022, 4:00 p.m.

/zigman2/quotes/230006699/composite

$

11.96

Change

0.00 0.00%

Volume

Volume 83

Quotes are delayed by 20 min

/zigman2/quotes/230006699/composite

Today's close

$ 12.11

$ 11.96

Change

-0.15 -1.24%

Day low

Day high

$11.50

$12.22

Open

52 week low

52 week high

$11.50

$23.21

Open

Annual Financials for Enfusion Inc.

Fiscal year is January-December. All values USD millions. 20192020 5-year trend
Sales/Revenue ---59.03M79.57M
Cost of Goods Sold (COGS) incl. D&A ---16.96M21.36M
COGS excluding D&A ---15.8M19.07M
Depreciation & Amortization Expense ---1.16M2.29M
Depreciation ---1.16M2.29M
Amortization of Intangibles -----
Gross Income ---42.07M58.21M
20192020 5-year trend
SG&A Expense ---28.2M52.13M
Research & Development ---4.15M6.32M
Other SG&A ---24.05M45.82M
Other Operating Expense -----
Unusual Expense -----
EBIT after Unusual Expense -----
Non Operating Income/Expense ---(3,000)82,000
Non-Operating Interest Income -----
Equity in Affiliates (Pretax) -----
Interest Expense ---724,0001.66M
Gross Interest Expense ---724,0001.66M
Interest Capitalized -----
Pretax Income ---13.14M4.49M
Income Tax ---486,000433,000
Income Tax - Current Domestic -----
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic -----
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income ---12.66M4.06M
Minority Interest Expense -----
Net Income ---12.66M4.06M
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries ---12.66M4.06M
Preferred Dividends -----
Net Income Available to Common ---12.66M4.06M
EPS (Basic) ---0.110.04
Basic Shares Outstanding ---113.05M113.05M
EPS (Diluted) ---0.110.04
Diluted Shares Outstanding ---113.05M113.05M
EBITDA ---15.03M8.37M
Link to MarketWatch's Slice.